Berkshire Hathaway vastly out-performed the S&P 500 last year. It should do well again this year, although I'm not sure if it will outperform. Read more here.Read full newsRead More
The US stock market has stabilized recently and trades moderately above its recent low. The current S&P 500 drawdown remains relatively steep.Read full newsRead More
One of the new developments is that Silvergate is offloading what they refer to as a few non-core customers. Click here to see our take on SI stock.Read full newsRead More
Service Properties Trust is a hotel and net lease REIT. The company, like many hotels, is climbing out of the COVID era. Click here to read our take on SVC bonds.Read full newsRead More
The future of genomics looks promising - here's what that means for the Global X Genomics & Biotechnology ETF.Read full newsRead More
Aveanna Healthcare Holdings has incredible revenues compared to their small market cap. Click here to read my analysis of AVAH stock.Read full newsRead More
iShares MSCI Mexico ETF provides targeted exposure to a basket of leading Mexican companies. Click here to read my analysis of EWW ETF.Read full newsRead More
Covered call CEFs remain popular in income portfolios due to their high yields, diversification from bonds and lower risk profile than stocks. Read more here.Read full newsRead More
WallStreetBets is a subreddit of retail traders that has gained notoriety for its role in the GameStop saga of January 2021. Read what's happening with BBBY.Read full newsRead More
My passive income was up by 46.50% on a year-over-year basis during December. For the full-year in 2022, my passive income rose by 23.73%. Click to read more.Read full newsRead More
QDIV favors high-yield S&P 500 stocks without compromising on quality. Click here to read why I believe QDIV ETF deserves a Buy rating.Read full newsRead More
We are all familiar with the realignment of expectations that has befallen the share prices of many companies focused on SaaS during 2022.Read full newsRead More
Personalis is a small-cap cancer genomics company whose stock has lost over 80% of its value over the past 12 months. Read why I rate PSNL stock a Buy.Read full newsRead More
General market performance. Premium discount behavior trends.Read full newsRead More
StoneCo continues to produce solid execution, despite challenging Brazilian economic and political conditions. See why I rate STNE a Buy for the long term.Read full newsRead More
Despite Performant Financial Corporation's less-than-stellar 2022 operating performance, shares have rallied in recent months. Read my take on PFMT stock here.Read full newsRead More
Progress Software Corporation (NASDAQ:NASDAQ:PRGS) Q4 2022 Earnings Conference Call January 17, 2023 5:00 PM ETCompany ParticipantsMichael Micciche - VP, IRYogesh Gupta - President and...Read full newsRead More
AbbVie is a quality BBB+ S&P credit rated healthcare stock with a 3.9% yield. Click here to read more about ABBV stock and my recommendation.Read full newsRead More
Visa continues to outperform the market and fully capitalize on the prolonged business cycle. Read why I believe V stock will continue to deliver higher returns.Read full newsRead More
Dow has recovered nearly 40% from its September/October lows. Click here to read why we downgrade DOW stock from a Buy to a Hold.Read full newsRead More